FDA Investigator Rabia Ballica, PhD

Rabia Ballica, PhD has inspections in 1 countries as of 20 Sep 2023. Rabia Ballica, PhD has collaborated with a combinined 1576 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
6
Last Inspection Date:
20 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100008787
Country:
United States of America
Co-Investigator(s):
Andrew "Drew" Haack, PhD, Andrew Haack, PhD, Andrew K Haack, PhD, Anita Narula, PhD, Barbara Janine Breithaupt, Brentley S Collins, Brian Janelsins, PhD, CDR Cecily Jones, CDR Donald Ertel, Cecily Javes, Charles Yuanchia Kuo, PhD, Chava Kimchi Sarfaty, PhD, Christopher R Czajka, Cristina Ausin Moreno, PhD, Cristina Ausin Moreoo, PhD, David E Bailey, Deborah M Trout, Diane L Raccasi, Eboni S Funderburk, Edwin Jao, Eileen A Liu, Emilie E Kahn, Esther C Broner, PhD, Hyung Yul Lee, Jacqueline Mdiaz Albertini, James A Lane, Jeffrey D Meng, Joan Johnson, Jon P Antoniou, Joslyn K Brunelle, PhD, Kathryn E King, Kimberly L Schultz, LCDR Debra Emerson, LCDR Sean Byrd, Lilia Bi, PhD, Lisa K Capron, Logan T Williams, Maria Cruz Fisher, Maria I Cruz Fisher, Meisha R Sampson, Meisha Waters, Michael S Araneta, Michael Shanks, MS, Michele L Forster, PhD, Michele Perry Williams, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Muna Algharibeh, Muna Alghribeh, Nancy T Waites, Nataniel Phillips Sylvain, PhD, Nicholas L Paulin, Nirjal Bhattarai, Prabhu P Raju, Ramjay Vatsan, PhD, Richard Ledwidge (nmi), PhD, Riley C Myers, PhD, Riley Meyers, Robert Aksamit, PhD, Robert Barbosa, Robert M Barbosa, S Lori Brown, PhD MPH, Sandra A Boyd, Sargum C Sood, Scott R Nichols, PhD, Sean R Bryd, Sneha S Patel, Steven E Bowen, PhD, Teegan Dellibovi Ragheb, PhD, Teena H Aiken, Timothy J Schmidt, V Teres Speer, Vaishali J Patel, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Wayne E Seifert, Yanming An, PhD, Yideng Liang, Yuan Chia Kuo, Zenobia Taraporewala, Zeuchia Tarapstewaka, PhD, Zhong Li, PhD

Rabia Ballica, PhD's Documents

Publish Date Document Type Title
October, 2020 EIR Juno Therapeutics, Inc. - EIR, 2020-10-16
October, 2020 FDA 483 Response Juno Therapeutics, Inc. - Form 483R, 2020-11-05
June, 2014 FDA 483 AGC Biologics, Inc. - Form 483, 2014-06-06
February, 2015 FDA 483 Biovex, Inc. - Form 483, 2015-02-13
February, 2015 FDA 483 Response Biovex, Inc. - Form 483R, 2015-02-27
February, 2012 EIR Catalent Indiana, LLC - EIR, 2012-02-24
August, 2017 FDA 483 Spark Therapeutics, Inc. - Form 483, 2017-08-25
June, 2014 EIR AGC Biologics, Inc. - EIR, 2014-06-06
August, 2017 EIR Spark Therapeutics, Inc. - EIR, 2017-08-25
August, 2017 FDA 483 Response Spark Therapeutics, Inc. - Form 483R, 2017-09-08
October, 2020 FDA 483 Juno Therapeutics, Inc. - Form 483, 2020-10-16
February, 2015 EIR Biovex, Inc. - EIR, 2015-02-13

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more